Prehospital high-dose methylprednisolone in resuscitated out-of-hospital cardiac arrest patients (STEROHCA): a randomized clinical trial.

Laust Emil Roelsgaard OblingRasmus P BeskeMartin A S MeyerJohannes GrandSebastian WibergBenjamin NyholmJakob JosiassenFrederik T SøndergaardThomas MohrAnders Damm-HejmdalMette BjerreRuth Frikke-SchmidtFredrik FolkeJacob E MøllerJesper KjaergaardChristian Hassager

Published in: Intensive care medicine (2023)

Prehospital treatment with high-dose methylprednisolone to resuscitated comatose OHCA patients, resulted in reduced IL-6 levels after 24 h, but did not reduce NSE levels.

Keyphrases

high dose
cardiac arrest
end stage renal disease
newly diagnosed
ejection fraction
low dose
prognostic factors
emergency medical